Anti-Midoriishi-Cyan mAb (Clone: 5B7)

Catalog No:
MBL-M130-3M
$805.00

Browse all MBL products from our MBL products homepage.



Product Specifications
Application WB
Clonality Monoclonal IgG1
Host Mouse
Immunogen Recombinant Midoriishi-Cyan
Formulation 100 μg IgG in 100 μl volume of PBS containing 50% glycerol, pH 7.2. No preservative is contained.
Documents & Links for Anti-Midoriishi-Cyan mAb (Clone: 5B7)
Datasheet Anti-Midoriishi-Cyan mAb (Clone: 5B7) Datasheet

Documents & Links for Anti-Midoriishi-Cyan mAb (Clone: 5B7)
Datasheet Anti-Midoriishi-Cyan mAb (Clone: 5B7) Datasheet

Citations for Anti-Midoriishi-Cyan mAb (Clone: 5B7) – 3 Found
Ideno, Hisashi; Nakashima, Kazuhisa; Komatsu, Koichiro; Araki, Ryoko; Abe, Masumi; Arai, Yoshinori; Kimura, Hiroshi; Shinkai, Yoichi; Tachibana, Makoto; Nifuji, Akira. G9a is involved in the regulation of cranial bone formation through activation of Runx2 function during development. Bone. 2020;137:115332.  PubMed
Comments: Used in: WB
Ideno, Hisashi; Nakashima, Kazuhisa; Komatsu, Koichiro; Araki, Ryoko; Abe, Masumi; Arai, Yoshinori; Kimura, Hiroshi; Shinkai, Yoichi; Tachibana, Makoto; Nifuji, Akira. G9a is involved in the regulation of cranial bone formation through activation of Runx2 function during development. Bone. 2020;137:115332.  PubMed
Comments: Used in: Co-IP
Ideno, Hisashi; Nakashima, Kazuhisa; Komatsu, Koichiro; Araki, Ryoko; Abe, Masumi; Arai, Yoshinori; Kimura, Hiroshi; Shinkai, Yoichi; Tachibana, Makoto; Nifuji, Akira. G9a is involved in the regulation of cranial bone formation through activation of Runx2 function during development. Bone. 2020;137:115332.  PubMed
Comments: Used in: ChIP